Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 36 | 2026 | 735 | 5.810 |
Why?
|
| Neuropsychological Tests | 44 | 2026 | 960 | 4.430 |
Why?
|
| Cognitive Dysfunction | 14 | 2026 | 338 | 3.500 |
Why?
|
| Dementia | 13 | 2026 | 436 | 3.290 |
Why?
|
| Cultural Competency | 5 | 2023 | 50 | 2.550 |
Why?
|
| Deep Brain Stimulation | 13 | 2021 | 446 | 2.510 |
Why?
|
| Cognition Disorders | 10 | 2025 | 556 | 1.330 |
Why?
|
| Language | 8 | 2023 | 219 | 0.950 |
Why?
|
| Cognition | 12 | 2025 | 829 | 0.950 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 878 | 0.930 |
Why?
|
| Pallidotomy | 3 | 2008 | 11 | 0.810 |
Why?
|
| Aged | 50 | 2026 | 21025 | 0.800 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2018 | 161 | 0.790 |
Why?
|
| Memory Disorders | 7 | 2020 | 204 | 0.770 |
Why?
|
| Verbal Behavior | 4 | 2010 | 45 | 0.750 |
Why?
|
| Globus Pallidus | 7 | 2014 | 64 | 0.750 |
Why?
|
| Neuropsychology | 2 | 2023 | 25 | 0.720 |
Why?
|
| Brain | 6 | 2026 | 3175 | 0.720 |
Why?
|
| Movement Disorders | 2 | 2021 | 218 | 0.700 |
Why?
|
| Subthalamic Nucleus | 4 | 2021 | 52 | 0.680 |
Why?
|
| Cues | 2 | 2019 | 80 | 0.660 |
Why?
|
| Life Style | 4 | 2026 | 456 | 0.640 |
Why?
|
| Neurosurgery | 1 | 2021 | 67 | 0.640 |
Why?
|
| Semantics | 2 | 2019 | 47 | 0.620 |
Why?
|
| Language Tests | 1 | 2019 | 24 | 0.590 |
Why?
|
| Temporal Lobe | 3 | 2010 | 110 | 0.550 |
Why?
|
| Humans | 81 | 2026 | 131163 | 0.530 |
Why?
|
| Frailty | 3 | 2026 | 140 | 0.520 |
Why?
|
| Quality of Life | 7 | 2024 | 2082 | 0.520 |
Why?
|
| Middle Aged | 41 | 2026 | 28601 | 0.510 |
Why?
|
| Pandemics | 3 | 2021 | 1118 | 0.460 |
Why?
|
| Verbal Learning | 4 | 2011 | 67 | 0.450 |
Why?
|
| Disease Progression | 8 | 2024 | 2200 | 0.440 |
Why?
|
| Male | 52 | 2026 | 64957 | 0.430 |
Why?
|
| Female | 53 | 2026 | 70963 | 0.420 |
Why?
|
| Functional Laterality | 9 | 2009 | 177 | 0.400 |
Why?
|
| Depression | 5 | 2021 | 1320 | 0.380 |
Why?
|
| Postoperative Complications | 6 | 2009 | 3147 | 0.360 |
Why?
|
| Pilot Projects | 5 | 2020 | 1445 | 0.360 |
Why?
|
| Speech Disorders | 1 | 2012 | 47 | 0.350 |
Why?
|
| Telemedicine | 4 | 2021 | 526 | 0.340 |
Why?
|
| Mental Recall | 1 | 2011 | 138 | 0.330 |
Why?
|
| Speech Articulation Tests | 1 | 2010 | 7 | 0.320 |
Why?
|
| Mental Processes | 3 | 2011 | 36 | 0.310 |
Why?
|
| Frontal Lobe | 1 | 2010 | 110 | 0.300 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 386 | 0.300 |
Why?
|
| Hippocampus | 2 | 2026 | 806 | 0.290 |
Why?
|
| Movement | 1 | 2007 | 147 | 0.240 |
Why?
|
| Aging | 3 | 2026 | 1242 | 0.230 |
Why?
|
| Cognitive Reserve | 1 | 2025 | 5 | 0.230 |
Why?
|
| United States | 12 | 2026 | 12072 | 0.220 |
Why?
|
| Forecasting | 3 | 2023 | 351 | 0.220 |
Why?
|
| Memory | 5 | 2011 | 314 | 0.220 |
Why?
|
| Individuality | 1 | 2025 | 40 | 0.220 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2025 | 21 | 0.220 |
Why?
|
| Risk Reduction Behavior | 1 | 2026 | 143 | 0.220 |
Why?
|
| Aged, 80 and over | 13 | 2022 | 6797 | 0.220 |
Why?
|
| Multimodal Imaging | 1 | 2026 | 109 | 0.220 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2026 | 171 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2026 | 3763 | 0.210 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2009 | 13 | 0.210 |
Why?
|
| Depressive Disorder | 1 | 2008 | 460 | 0.210 |
Why?
|
| Parkinsonian Disorders | 2 | 2018 | 76 | 0.210 |
Why?
|
| Dopamine | 1 | 2025 | 246 | 0.200 |
Why?
|
| Frail Elderly | 1 | 2025 | 107 | 0.200 |
Why?
|
| Essential Tremor | 1 | 2025 | 96 | 0.200 |
Why?
|
| Occupational Therapy | 1 | 2024 | 37 | 0.200 |
Why?
|
| White Matter | 1 | 2026 | 219 | 0.200 |
Why?
|
| Translations | 1 | 2023 | 18 | 0.200 |
Why?
|
| Mood Disorders | 2 | 2018 | 129 | 0.190 |
Why?
|
| Translating | 1 | 2023 | 30 | 0.190 |
Why?
|
| Republic of Korea | 1 | 2023 | 50 | 0.190 |
Why?
|
| Cohort Studies | 6 | 2025 | 5063 | 0.190 |
Why?
|
| Multimorbidity | 1 | 2023 | 23 | 0.190 |
Why?
|
| Vietnam | 1 | 2023 | 61 | 0.190 |
Why?
|
| Motivation | 2 | 2018 | 328 | 0.190 |
Why?
|
| tau Proteins | 1 | 2025 | 257 | 0.190 |
Why?
|
| Treatment Outcome | 12 | 2017 | 12936 | 0.190 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 4066 | 0.190 |
Why?
|
| Culturally Competent Care | 1 | 2023 | 50 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2026 | 385 | 0.180 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 92 | 0.170 |
Why?
|
| Quarantine | 1 | 2021 | 19 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 21 | 0.170 |
Why?
|
| Walking Speed | 1 | 2021 | 19 | 0.170 |
Why?
|
| Feasibility Studies | 3 | 2022 | 824 | 0.160 |
Why?
|
| Analysis of Variance | 5 | 2018 | 928 | 0.160 |
Why?
|
| HIV Seropositivity | 1 | 2001 | 123 | 0.160 |
Why?
|
| Psychomotor Performance | 3 | 2014 | 174 | 0.160 |
Why?
|
| Preoperative Care | 2 | 2021 | 358 | 0.160 |
Why?
|
| Behavioral Symptoms | 1 | 2020 | 27 | 0.150 |
Why?
|
| Educational Status | 3 | 2025 | 279 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 129 | 0.150 |
Why?
|
| Frontotemporal Dementia | 2 | 2010 | 56 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2021 | 294 | 0.150 |
Why?
|
| Gait | 2 | 2021 | 141 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 128 | 0.150 |
Why?
|
| Visual Perception | 2 | 2011 | 128 | 0.150 |
Why?
|
| Exercise | 3 | 2026 | 892 | 0.140 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2018 | 13 | 0.130 |
Why?
|
| Emotions | 2 | 2011 | 350 | 0.130 |
Why?
|
| Electrodes, Implanted | 2 | 2009 | 180 | 0.130 |
Why?
|
| Restless Legs Syndrome | 1 | 2018 | 16 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2023 | 1882 | 0.130 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 184 | 0.130 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 5196 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1490 | 0.130 |
Why?
|
| Anxiety | 2 | 2015 | 1014 | 0.120 |
Why?
|
| Executive Function | 3 | 2014 | 122 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2023 | 1106 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2019 | 442 | 0.120 |
Why?
|
| Irritants | 1 | 1995 | 8 | 0.120 |
Why?
|
| Erythema | 1 | 1995 | 29 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2024 | 6459 | 0.110 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 74 | 0.110 |
Why?
|
| Edema | 1 | 1995 | 130 | 0.110 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 321 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2021 | 17753 | 0.110 |
Why?
|
| Medication Adherence | 2 | 2015 | 338 | 0.100 |
Why?
|
| Exercise Therapy | 3 | 2022 | 173 | 0.100 |
Why?
|
| Adult | 15 | 2020 | 31282 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 2904 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2018 | 562 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 464 | 0.100 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 33 | 0.100 |
Why?
|
| Compulsive Behavior | 1 | 2014 | 45 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 3061 | 0.100 |
Why?
|
| Motor Activity | 2 | 2011 | 489 | 0.090 |
Why?
|
| Comorbidity | 4 | 2019 | 1595 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 63 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2121 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 226 | 0.090 |
Why?
|
| Antiparasitic Agents | 1 | 2012 | 28 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 177 | 0.090 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 20 | 0.090 |
Why?
|
| Space Perception | 2 | 2009 | 50 | 0.090 |
Why?
|
| Levodopa | 1 | 2012 | 92 | 0.090 |
Why?
|
| Language Disorders | 2 | 2009 | 21 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2013 | 516 | 0.080 |
Why?
|
| Demography | 1 | 2011 | 237 | 0.080 |
Why?
|
| Patient Admission | 1 | 2012 | 185 | 0.080 |
Why?
|
| Sneddon Syndrome | 1 | 2010 | 3 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 676 | 0.080 |
Why?
|
| Behavior | 1 | 2010 | 70 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 187 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 65 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 49 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 592 | 0.070 |
Why?
|
| Specialization | 1 | 2010 | 75 | 0.070 |
Why?
|
| Base Sequence | 1 | 2013 | 2730 | 0.070 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2009 | 6 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2010 | 414 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2011 | 295 | 0.070 |
Why?
|
| Chorea | 1 | 2009 | 33 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2009 | 52 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2009 | 191 | 0.070 |
Why?
|
| Memory, Short-Term | 1 | 2009 | 138 | 0.070 |
Why?
|
| Survival Rate | 2 | 2010 | 2114 | 0.070 |
Why?
|
| Stereotaxic Techniques | 2 | 1999 | 102 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 428 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2009 | 126 | 0.070 |
Why?
|
| Reaction Time | 1 | 2008 | 152 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2015 | 3711 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2008 | 185 | 0.060 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2006 | 12 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 587 | 0.060 |
Why?
|
| Unemployment | 1 | 2006 | 25 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2010 | 401 | 0.060 |
Why?
|
| Patch Tests | 2 | 1997 | 7 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2006 | 62 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 395 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 663 | 0.060 |
Why?
|
| Entorhinal Cortex | 1 | 2025 | 28 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 2701 | 0.060 |
Why?
|
| Software | 1 | 2010 | 733 | 0.050 |
Why?
|
| Risk Factors | 3 | 2025 | 11074 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 23 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 6196 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 229 | 0.050 |
Why?
|
| Reoperation | 1 | 2007 | 818 | 0.050 |
Why?
|
| Speech Therapy | 1 | 2024 | 14 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 143 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2025 | 279 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 1717 | 0.050 |
Why?
|
| Biomarkers | 2 | 2025 | 3385 | 0.050 |
Why?
|
| Taiwan | 1 | 2023 | 38 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 830 | 0.050 |
Why?
|
| Sclerosis | 1 | 2003 | 31 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 93 | 0.050 |
Why?
|
| HIV Infections | 1 | 2015 | 2049 | 0.050 |
Why?
|
| Phonetics | 1 | 2003 | 24 | 0.050 |
Why?
|
| Vocabulary | 1 | 2003 | 20 | 0.050 |
Why?
|
| Brazil | 1 | 2023 | 116 | 0.050 |
Why?
|
| Reward | 1 | 2004 | 140 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 761 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1950 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3829 | 0.050 |
Why?
|
| China | 1 | 2023 | 278 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3436 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2003 | 331 | 0.040 |
Why?
|
| Neurosurgeons | 1 | 2021 | 10 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 2001 | 54 | 0.040 |
Why?
|
| Neurologists | 1 | 2021 | 25 | 0.040 |
Why?
|
| Veterans | 2 | 2012 | 1763 | 0.040 |
Why?
|
| Psychometrics | 1 | 2025 | 678 | 0.040 |
Why?
|
| Speech Perception | 1 | 2001 | 53 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 276 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 327 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Thalamic Nuclei | 1 | 1999 | 19 | 0.040 |
Why?
|
| Motor Skills | 1 | 1999 | 72 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1459 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 230 | 0.040 |
Why?
|
| Affect | 1 | 1999 | 159 | 0.040 |
Why?
|
| Attention | 2 | 2010 | 194 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 336 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 214 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 1153 | 0.030 |
Why?
|
| Caregivers | 1 | 2022 | 598 | 0.030 |
Why?
|
| Time | 1 | 2016 | 92 | 0.030 |
Why?
|
| Cetrimonium Compounds | 1 | 1995 | 4 | 0.030 |
Why?
|
| Patient Selection | 1 | 1999 | 729 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1995 | 15 | 0.030 |
Why?
|
| Sodium Hydroxide | 1 | 1995 | 6 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1995 | 17 | 0.030 |
Why?
|
| Cyclohexenes | 1 | 1995 | 12 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1995 | 24 | 0.030 |
Why?
|
| Terpenes | 1 | 1995 | 30 | 0.030 |
Why?
|
| Acetates | 1 | 1995 | 77 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 133 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 111 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 554 | 0.030 |
Why?
|
| Logistic Models | 2 | 2009 | 1797 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1979 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 523 | 0.030 |
Why?
|
| Allergens | 1 | 1997 | 344 | 0.030 |
Why?
|
| Adolescent | 3 | 2006 | 20987 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 447 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 294 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 121 | 0.020 |
Why?
|
| Health Surveys | 1 | 2014 | 261 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 19 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2012 | 34 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 138 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 423 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 759 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 239 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 106 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 192 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1677 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 136 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 161 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 23 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1295 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 74 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 141 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 915 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3464 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 198 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2010 | 143 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 185 | 0.020 |
Why?
|
| Child | 2 | 2013 | 26341 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 116 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 262 | 0.020 |
Why?
|
| Face | 1 | 2009 | 192 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 545 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 305 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1447 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 563 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 356 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 272 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1211 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 729 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2085 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 10103 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2595 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 712 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 890 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 743 | 0.010 |
Why?
|
| Motor Skills Disorders | 1 | 2000 | 9 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1998 | 37 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2426 | 0.010 |
Why?
|
| Hemiplegia | 1 | 1998 | 40 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1680 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 15110 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 158 | 0.010 |
Why?
|
| Reference Standards | 1 | 1997 | 231 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 33912 | 0.000 |
Why?
|